EMT in tumor cells is characterized by changes in biomarkers, such as cell membrane proteins, cytoskeletal proteins, extracellular matrix proteins and some transcription factors, in addition to changes in the cellular morphology, cell polarity and ability to migrate and invade. This evidence concerns the gene DNM2 and neoplasm.